The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine
NCT ID: NCT02477293
Last Updated: 2016-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2015-08-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyeonggaeyeongyo-tang
Hyeonggaeyeongyo-tang
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyeonggaeyeongyo-tang
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one of the following conditions: Nasal congestion, rhinorrhea, sneeze, pruritus
* At least one of the following Moderate abnormality conditions: sleep disturbance; daily activity, physical exercise, leisure activity limitations; work/school work limitations; discomfort with several symptoms
2. Age between 19 and 65 years
3. Able to dialogue
4. Agree with informed consent
Exclusion Criteria
* Drugs which determined to have negative effect on symptoms of rhinitis or skin prick test (oral or nasal)
* Short acting anti-histamines / H1 blockers (drug use within lase 1 week)
* Long acting anti-histamines / H1 blockers (drug use within lase 2 week)
* Corticosteroids (drug use within lase 1 month) ④ Anti-cholinergic drug (drug use within lase 1 week)
* Anti-leukotriene drug (drug use within lase 1 week)
* Decongestants (drug use within lase 1 week) ⑦ Tricyclic antidepressants, phenothiazines (drug use within lase 2 week) ⑧ Non-steroidal analgesics (drug use within lase 1 week) ⑨ Drugs that is judged to be inappropriate for the trial by the researchers
2. Used Korean medicine for treating rhinitis within last 7 days
3. Patients who has severe disease, such as malignant tumor, severe dyslipidemia, liver or kidney dysfunction, anemia, active pulmonary tuberculosis, infection or systemic disease etc
4. Presence of internal nasal obstruction or nasal deformities or history of nasal surgery within 2 months
5. History of active respiratory disease(ex. asthma)
6. Hypertension or Diabetes
7. Experienced immunotherapy or systemic steroid treatments within last 3 months
8. Experienced drug allergic reactions
9. Experienced anaphylactic reactions, during allergen test
10. Female patients who are pregnant or lactating or have the chances of pregnancy
11. Patients who are participated other clinical trials within last 1 month
12. Patients who are unable to participate the trial (paralysis, severe mental or psychological illness, dementia, drug addiction, unable to make to participate in the trial, severe visual or auditory dysfunction, unable to visit hospital regularly, unable to communicate through spoken or written Korean etc)
13. Patients who are judged to be inappropriate for the clinical study by the researchers
19 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyung Hee University Hospital at Gangdong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Minhee Kim
KMD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seong-Kyu Ko, KMD, PhD
Role: STUDY_CHAIR
Kyunghee University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyung Hee University Hospital at Gangdong
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim MH, Son J, Nam HJ, Ko SG, Choi I. Hyeonggaeyeongyo-Tang for Treatment of Allergic and Nonallergic Rhinitis: A Prospective, Nonrandomized, Pre-Post Study. Evid Based Complement Alternat Med. 2016;2016:9202675. doi: 10.1155/2016/9202675. Epub 2016 Sep 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B120014
Identifier Type: -
Identifier Source: org_study_id